02/20/2025
3:10 PM | Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
6:30 PM | Beam Therapeutics (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/03/2025
3:05 PM | Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:05 PM | Beam Therapeutics (Issuer)
Evans John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:05 PM | Beam Therapeutics (Issuer)
Simon Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:05 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:05 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
3:12 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
6:05 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
8:46 PM | ARK Investment Management LLC (Filed by)
Beam Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/06/2025
4:48 PM | Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BEAM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Beam Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/06/2025
4:49 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
7:04 PM | Beam Therapeutics (Issuer)
Emany Sravan Kumar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
6:26 PM | Beam Therapeutics (Subject)
Bellon Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/30/2024
6:29 PM | Beam Therapeutics (Subject)
Cavanagh Bethany J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2024
3:10 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
6:01 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
6:06 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2024
6:18 AM | Beam Therapeutics (Issuer)
Guindo Chirfi (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/04/2024
6:22 AM | Beam Therapeutics (Issuer)
Guindo Chirfi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2024
6:08 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
3:10 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
8:56 AM | Beam Therapeutics (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
11/05/2024
8:00 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
8:06 AM | Beam Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
7:30 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
6:05 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
10:50 AM | Beam Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/16/2024
3:44 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
10:37 AM | Beam Therapeutics (Subject)
Ciaramella Giuseppe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/07/2024
4:00 PM | Beam Therapeutics (Subject)
Burrell Terry-Ann (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
4:51 PM | Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:52 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:49 PM | Beam Therapeutics (Issuer)
Evans John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:51 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:15 PM | Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/06/2024
6:08 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
6:01 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
3:14 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
3:30 PM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
3:42 PM | Beam Therapeutics (Issuer)
Fishman Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Nvidia > DeepSeek (Ad) Everyone's getting it all wrong …
Sure, DeepSeek's reveal caused AI stocks to tumble …
But, in the long run … that's a good thing. Click here to see why Nvidia's bad day could end up being a great year. |
06/07/2024
3:42 PM | Beam Therapeutics (Issuer)
Walsh Kathleen E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:45 PM | Beam Therapeutics (Issuer)
COOPER GRAHAM K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:47 PM | Beam Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:47 PM | Beam Therapeutics (Issuer)
MARAGANORE JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:48 PM | Beam Therapeutics (Issuer)
Shaw Christi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
6:09 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
6:19 AM | Beam Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/19/2024
3:25 PM | Beam Therapeutics (Filer)
| Form ARS | |
04/19/2024
3:15 PM | Beam Therapeutics (Filer)
| Form DEF 14A | |
04/19/2024
3:20 PM | Beam Therapeutics (Filer)
| Form DEFA14A | |
04/04/2024
7:56 PM | Beam Therapeutics (Subject)
Ciaramella Giuseppe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
7:57 PM | Beam Therapeutics (Subject)
Burrell Terry-Ann (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
7:57 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
7:55 PM | Beam Therapeutics (Subject)
Simon Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
7:56 PM | Beam Therapeutics (Subject)
Bellon Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
6:39 PM | Beam Therapeutics (Issuer)
Burrell Terry-Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:40 PM | Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:43 PM | Beam Therapeutics (Issuer)
Simon Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:33 PM | Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:36 PM | Beam Therapeutics (Issuer)
Evans John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:22 PM | Beam Therapeutics (Subject)
Simon Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
3:10 PM | Beam Therapeutics (Issuer)
Simon Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:10 PM | Beam Therapeutics (Issuer)
Burrell Terry-Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
5:13 PM | Beam Therapeutics (Subject)
Evans John M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
6:40 AM | Beam Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
6:22 AM | Beam Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
5:43 AM | Beam Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free BEAM Stock Alerts